Cargando…
A case report: The efficacy of pirfenidone in a Chinese patient with progressive systemic sclerosis-associated interstitial lung disease: A CARE-compliant article
Systemic sclerosis (SSc)-associated interstitial lung disease (SSc-ILD) has become the leading SSc-related cause of death. Although various types of immunosuppressive therapy have been attempted for patients with SSc-ILD, no curative or effective treatment strategies for SSc-ILD have been developed....
Autores principales: | Huang, Hui, Feng, Rui E., Li, Shan, Xu, Kai, Bi, Ya Lan, Xu, Zuo Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058843/ https://www.ncbi.nlm.nih.gov/pubmed/27399114 http://dx.doi.org/10.1097/MD.0000000000004113 |
Ejemplares similares
-
Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients
por: Huang, Hui, et al.
Publicado: (2015) -
A CARE-compliant case report: Lung transplantation for a Chinese young man with idiopathic pleuroparenchymal fibroelastosis
por: Huang, Hui, et al.
Publicado: (2017) -
Castleman disease-associated diffuse parenchymal lung disease: A STROBE-compliant retrospective observational analysis of 22 cases in a tertiary Chinese hospital
por: Huang, Hui, et al.
Publicado: (2017) -
A CARE-compliant article: A case report and literature review of IgG4-related lung disease
por: Ren, Hongmei, et al.
Publicado: (2022) -
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022)